7498 Results (Page 229 of 300)
Pharmaceuticals Markets Research Reports
Hong Kong Pharmaceutical Market Analysis
This report presents a strategic analysis of the Hong Kong Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Hong Kong Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Bulgaria ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
This report presents a strategic analysis of the Bulgaria ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Bulgaria ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy and expert insights.
US Rheumatology Drugs Market Analysis
The US Rheumatology Drugs Market is projected to grow from $25.641 Bn in 2022 to $27.329 Bn by 2030, registering a CAGR of 0.8% during the forecast period of 2022-2030. The development of new biologic drugs, such as tumour necrosis factor (TNF) inhibitors, interleukin (IL)-6 inhibitors, and Janus kinase (JAK) inhibitors, has expanded the treatment options for rheumatic conditions, driving the market growth. Pfizer is one of the leading pharmaceutical companies in the world and offers a range of rheumatology drugs, including TNF inhibitors and JAK inhibitors.
UAE Dermatology Drugs Market Analysis
By 2030, it is anticipated that the UAE Dermatology drugs market will reach a value of $207.47 Mn from $85 Mn in 2022, growing at a CAGR of 11.8% during 2022-2030. The market is primarily dominated by local players such as Gulf Pharmaceutical Industries, Neopharma, and Julphar. The market is driven by slow research and development, increasing disease prevalence, and government regulations. The dermatology drug market in UAE is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
South Africa Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the South Africa Oncology Therapeutics Market will reach a value of $2.5 Bn from $1.2 Bn in 2022, growing at a CAGR of 9.6% during 2022-2030. The Oncology Therapeutics Market in South Africa is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare, Adcock Ingram, and Roche South Africa. The Oncology Therapeutics Market in South Africa is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for South Africa Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
South Africa Acne Therapeutics Market Analysis
This report presents a strategic analysis of the South Africa Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Africa Acne Therapeutics Market, offering unmatched value, accuracy and expert insights.
Singapore Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Singapore Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Singapore Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Indonesia Vaccines Market Analysis
This report presents a strategic analysis of the Indonesia Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Indonesia Vaccines Market, offering unmatched value, accuracy and expert insights.
India Antibacterial (Antibiotics) Drugs Market Analysis
This report presents a strategic analysis of the India Antibacterial (Antibiotics) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Antibacterial (Antibiotics) Drugs Market, offering unmatched value, accuracy and expert insights.
Brazil Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Brazil dermatology drugs market will reach a value of $1037.35 Mn from $425 Mn in 2022, growing at a CAGR of 11.8% during 2022-2030. The market is primarily dominated by local players such as Neo Química, Eurofarma, and EMS S.A. The market is driven by Telemedicine, OTC, and government regulations. The dermatology drug market in Brazil is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Spain Dialysis Market Analysis
Spain's Dialysis Market is projected to grow from $2.243 Bn in 2022 to $ Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-2030. The increasing incidence of CKD in Spain is another key driver of the dialysis market. CKD is a leading cause of end-stage renal disease (ESRD), which requires dialysis or kidney transplantation. Some key players in the Spain dialysis market include Fresenius Medical Care, Nipro Medical Corporation, and Diaverum.
Kenya Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Kenya Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Kenya Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Germany Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Germany dermatology drugs market will reach a value of $1,240 Mn from $622 Mn in 2022, growing at a CAGR of 9% during 2022-2030. The market is primarily dominated by local players such as Merck KGaA, Stada Arzneimittel, and Beiersdorf. The market is driven by innovation and development, better health insurance, and strict regulations. The dermatology drug market in Germany is segmented by drug class, drug type, prescription mode, indication, route of administration, end user and distribution channel.
Nigeria Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Nigeria Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Nigeria Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Malaysia Dialysis Market Analysis
This report presents a strategic analysis of the Malaysia Dialysis Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Malaysia Dialysis Market, offering unmatched value, accuracy and expert insights.
India Biosimilars Market Analysis
India's biosimilars market size was valued at $349 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 25.2% from 2022 to 2030 and will reach $2108 Mn in 2030. The market is segmented by product type and indication type. The Indian Biosimilars market will grow as India biosimilar market is driven by its cost-effective manufacturing capabilities. The key market players are Biocon Ltd (IND), Intas Pharmaceuticals Ltd (IND), Dr. Reddy's Laboratories Ltd (IND), Reliance Life Sciences Pvt. Ltd (IND), Zydus Cadila Healthcare Ltd (IND), Lupin Limited (IND)and others.
Japan Dialysis Market Analysis
Japan's Dialysis Market is projected to grow from $7.223 Bn in 2022 to $12.411 Bn by 2030, registering a CAGR of 7% during the forecast period of 2022 – 2030. The Japanese government has implemented several policies and regulations to support the development of the dialysis market in the country, such as the Long-term Care Insurance (LTCI) system, which covers the cost of dialysis treatment for eligible individuals, and the Basic Act for Health Insurance, which includes regulations for the provision of dialysis services. Some key players in the Japan dialysis market include Fresenius Medical Care, Baxter International, Nipro Medical Corporation, Nikkiso, Kawasumi Laboratories, and DaVita.
Germany Oncology Drugs Market Analysis
The oncology drugs market in Germany is a significant and growing market, as cancer is a major public health issue. According to a report published by Insights10, the oncology drugs market in Germany was valued at $7.19 Bn in 2022 and is expected to reach $15.19 Bn by 2030, at a CAGR of 9.8% during the forecast period. The market is highly competitive, with a large number of players like Baxter, Daiichi Sankyo Europe, Novartis etc offering a wide range of cancer treatment options.
Egypt ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
This report presents a strategic analysis of the Egypt ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy and expert insights.
US Obesity Drugs Market Analysis
The US obesity drugs market is projected to grow from $1.2 Bn in 2022 to $5.2 Bn by 2030, registering a CAGR of 20.3% during the forecast period of 2022-30. There is increasing awareness of the health risks associated with obesity, including heart disease, diabetes, and high blood pressure. This is driving demand for effective treatments that can help reduce the risk of these conditions. Novo Nordisk, a Danish pharmaceutical company is a major player in the obesity drugs market, with a portfolio of products that includes Saxenda (liraglutide), an injectable drug approved for weight loss in adults with obesity.
South Africa Retail Pharmacy Market Analysis
This report presents a strategic analysis of the South Africa Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Africa Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Nigeria Oncology Drugs Market Analysis
This report presents a strategic analysis of the Nigeria Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Nigeria Oncology Drugs Market, offering unmatched value, accuracy and expert insights.
South Korea Oncology Drugs Market Analysis
South Korea's oncology drugs market size is at around $2.89 Bn in 2022 and is projected to reach $7.41 Bn in 2030, exhibiting a CAGR of 12.6% during the forecast period 2022-2030. The oncology industry is being segmented into drug class, therapy, indication, and dosage. The driving factors for the oncology drug market are increasing awareness among people, cutting-edge technology, and increasing clinical trials. Company examples: Bristol-Myers Squibb, Roche, Merck & Co, Novartis, Johnson & Johnson
Malaysia Sleep Disorders Market Analysis
This report presents a strategic analysis of the Malaysia Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Malaysia Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
Qatar Pharmaceutical Market Analysis
This report presents a strategic analysis of the Qatar Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Qatar Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
